✦ LIBER ✦

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

✍ Scribed by Maria Debiec-Rychter; Raf Sciot; Axel Le Cesne; Marcus Schlemmer; Peter Hohenberger; Allan T. van Oosterom; Jean-Yves Blay; Serge Leyvraz; Michel Stul; Paolo G. Casali; John Zalcberg; Jaap Verweij; Martine Van Glabbeke; Anne Hagemeijer; Ian Judson

Book ID: 116428912
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 268 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2006.01.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C-KIT mutations were closely associated

C-KIT mutations were closely associated with the response to Imatinib in Chinese advanced gastrointestinal stromal tumor patients

✍ Jing Gao, Yunzhi Dang, Naiping Sun, Jian Li, Lin Shen 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 296 KB

Pathological response of gastrointestina

Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones

✍ M B Loughrey; V Beshay; A Dobrovic; J Zalcberg; P M Waring 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB

Late resistance to imatinib therapy in a

Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation

✍ Wakai, T; Kanda, T; Hirota, S; Ohashi, A; Shirai, Y; Hatakeyama, K 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

Clinical evaluation of continuous daily

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

✍ S. George; J.Y. Blay; P.G. Casali; A. Le Cesne; P. Stephenson; S.E. DePrimo; C.S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 523 KB

Resistance to imatinib, low-grade FDG-av

Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour

✍ Florian Grimpen; Desmond Yip; Grant McArthur; Paul Waring; David Goldstein; Maur 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 260 KB

6625 A cross sectional study of Imatinib

6625 A cross sectional study of Imatinib trough plasma level in patients with advanced gastrointestinal stromal tumour

✍ Yoo, C.; Kang, B.W.; Ryu, M.H.; Yoon, S.K.; Ryoo, B.Y.; Chang, H.M.; Lee, J.L.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB